Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Sun, Li Yi ^a   Pang, Cheng Yoong ^a,b   Li, Dian Kun ^a,b   Liao, Chia Hsin ^a,b   Huang, Wei Chao ^a   Wu, Chao Chuan ^a   Chou, Yi Yo ^a   Li, Wei Wu ^a   Chen, Shin Yuan ^a   Liu, Hwan Wun ^a   Chang, Yao Jen ^a   Cheng, Ching Feng ^a,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Adipose derived mesenchymal stem cells; Antioxidant; Fibroblast growth factor 2; Hypoxia

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID 2 PHOSPHATE; BETA ACTIN; BETA1 INTEGRIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; PROTEIN P21; PROTEIN P27; THY 1 ANTIGEN; ANTIOXIDANT; CDK1 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ARTICLE; BONE DEVELOPMENT; CELL AGING; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; TELOMERE; WESTERN BLOTTING; ADIPOSE TISSUE; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL DIVISION; CELL HYPOXIA; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL;

ADIPOSE TISSUE; ANTIOXIDANTS; CELL DIVISION; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84880872289     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-53     Document Type: Article

References (41)

1. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Yao Y, Zhang F, Wang L, Zhang G, Wang Z, Chen J, Gao X, J Biomed Sci 2009 16 74 10.1186/1423-0127-16-74 19691857
2. Umbilical cord-derived mesenchymal stem cells with forced expression of hepatocyte growth factor enhance remyelination and functional recovery in a rat intracerebral hemorrhage model. Liu AM, Lu G, Tsang KS, Li G, Wu Y, Huang ZS, Ng HK, Kung HF, Poon WS, Neurosurgery 2010 67 357 365 discussion 365-356 10.1227/01.NEU.0000371983.06278.B3 20644422
3. Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Wong VW, Rustad KC, Glotzbach JP, Sorkin M, Inayathullah M, Major MR, Longaker MT, Rajadas J, Gurtner GC, Macromol Biosci 2011 11 1458 1466 21994074
4. Culture systems for pluripotent stem cells. Ulloa-Montoya F, Verfaillie CM, Hu WS, J Biosci Bioeng 2005 100 12 27 10.1263/jbb.100.12 16233846 (Pubitemid 41569341)
5. Bioreactor development for stem cell expansion and controlled differentiation. King JA, Miller WM, Curr Opin Chem Biol 2007 11 394 398 10.1016/j.cbpa.2007.05.034 17656148 (Pubitemid 47302847)
6. Effect of pulsed electromagnetic field on the proliferation and differentiation potential of human bone marrow mesenchymal stem cells. Sun LY, Hsieh DK, Yu TC, Chiu HT, Lu SF, Luo GH, Kuo TK, Lee OK, Chiou TW, Bioelectromagnetics 2009 30 251 260 10.1002/bem.20472 19204973
7. Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential. Sun LY, Hsieh DK, Syu WS, Li YS, Chiu HT, Chiou TW, Cell Prolif 2010 43 445 456 10.1111/j.1365-2184.2010.00694.x 20887551
8. Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M, Bron D, Lagneaux L, Eur J Haematol 2006 76 309 316 10.1111/j.1600-0609.2005.00611.x 16519702 (Pubitemid 43362939)
9. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ, Blood 2004 103 1647 1652 10.1182/blood-2003-06-1967 14630823 (Pubitemid 38268955)
10. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Muller AM, Davenport M, Verrier S, Droeser R, Alini M, Bocelli-Tyndall C, Schaefer DJ, Martin I, Scherberich A, Tissue Eng Part A 2009 15 869 875 10.1089/ten.tea.2008. 0498 19191518
11. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R, Endocrinology 1997 138 4456 4462 10.1210/en.138.10.4456 9322963 (Pubitemid 27408494)
12. Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. Sheehy EJ, Buckley CT, Kelly DJ, Biochem Biophys Res Commun 2012 417 305 310 10.1016/j.bbrc.2011.11.105 22155244
13. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. Hung SP, Ho JH, Shih YR, Lo T, Lee OK, J Orthop Res 2012 30 260 266 10.1002/jor.21517 21809383
14. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, Prockop DJ, PLoS One 2007 2 416 10.1371/journal.pone.0000416 17476338
15. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Liu H, Xue W, Ge G, Luo X, Li Y, Xiang H, Ding X, Tian P, Tian X, Biochem Biophys Res Commun 2010 401 509 515 10.1016/j.bbrc.2010.09.076 20869949
16. Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Lin TM, Tsai JL, Lin SD, Lai CS, Chang CC, Stem Cells Dev 2005 14 92 102 10.1089/scd.2005.14.92 15725748
17. Optimizing proliferation and characterization of multipotent stem cells from porcine adipose tissue. Wang KH, Kao AP, Wangchen H, Wang FY, Chang CH, Chang CC, Lin SD, Biotechnol Appl Biochem 2008 51 159 166 10.1042/BA20070201 18279148
18. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS, Cell Physiol Biochem 2004 14 311 324 10.1159/000080341 15319535 (Pubitemid 39179200)
19. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I, Cell Tissue Res 2007 327 449 462 10.1007/s00441-006-0308-z 17053900 (Pubitemid 46232315)
20. Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion. Park BS, Kim WS, Choi JS, Kim HK, Won JH, Ohkubo F, Fukuoka H, Biomed Res 2010 31 27 34 10.2220/biomedres.31.27 20203417
21. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL, Circulation 2004 109 1292 1298 10.1161/01.CIR.0000121425.42966.F1 14993122 (Pubitemid 38372789)
22. Adipose-derived stem cell: a better stem cell than BMSC. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z, Cell Biochem Funct 2008 26 664 675 10.1002/cbf.1488 18636461
23. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, et al. Cytotherapy 2011 13 675 685 10.3109/14653249.2010.549122 21231804
24. High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ, Li Y, Li YL, J Biomed Sci 2011 18 59 10.1186/1423-0127-18-59 21854621
25. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R, Exp Cell Res 2003 287 98 105 10.1016/S0014-4827(03)00138-1 12799186 (Pubitemid 36683205)
26. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF, J Cell Physiol 2005 203 398 409 10.1002/jcp.20238 15521064 (Pubitemid 40471774)
27. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC, Cells Tissues Organs 2010 192 106 115 10.1159/000289586 20185896
28. Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor. Lin PC, Chen YL, Chiu SC, Yu YL, Chen SP, Chien MH, Chen KY, Chang WL, Lin SZ, Chiou TW, Harn HJ, J Neurochem 2008 106 1017 1026 10.1111/j.1471-4159.2008.05432.x 18419761
29. Telomere measurement by quantitative PCR. Cawthon RM, Nucleic Acids Res 2002 30 47 10.1093/nar/30.10.e47 12000852
30. Induction of apoptosis coupled to endoplasmic reticulum stress in human prostate cancer cells by n-butylidenephthalide. Chiu SC, Chen SP, Huang SY, Wang MJ, Lin SZ, Harn HJ, Pang CY, PLoS One 2012 7 33742 10.1371/journal.pone. 0033742 22470469
31. Ascorbic acid induces in vitro proliferation of human subcutaneous adipose tissue derived mesenchymal stem cells with upregulation of embryonic stem cell pluripotency markers Oct4 and SOX 2. Potdar PD, D'Souza SB, Hum Cell 2010 23 152 155 10.1111/j.1749-0774.2010.00095.x 21166886
32. Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells. Kanda Y, Hinata T, Kang SW, Watanabe Y, Life Sci 2011 89 250 258 10.1016/j.lfs.2011.06.007 21722651
33. Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. Tamama K, Kawasaki H, Kerpedjieva SS, Guan J, Ganju RK, Sen CK, J Cell Biochem 2011 112 804 817 10.1002/jcb.22961 21328454
34. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Song H, Cha MJ, Song BW, Kim IK, Chang W, Lim S, Choi EJ, Ham O, Lee SY, Chung N, et al. Stem Cells 2010 28 555 563 20073042
35. Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE, J Endocrinol 1999 160 257 266 10.1677/joe.0.1600257 9924195 (Pubitemid 29074696)
36. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Tsai CC, Chen YJ, Yew TL, Chen LL, Wang JY, Chiu CH, Hung SC, Blood 2011 117 459 469 10.1182/blood-2010-05-287508 20952688
37. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Adesida AB, Mulet-Sierra A, Jomha NM, Stem Cell Res Ther 2012 3 9 10.1186/scrt100 22385573
38. Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Nekanti U, Dastidar S, Venugopal P, Totey S, Ta M, Int J Biol Sci 2010 6 499 512 20877435
39. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Rosova I, Dao M, Capoccia B, Link D, Nolta JA, Stem Cells 2008 26 2173 2182 10.1634/stemcells.2007-1104 18511601
40. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Rochefort GY, Delorme B, Lopez A, Herault O, Bonnet P, Charbord P, Eder V, Domenech J, Stem Cells 2006 24 2202 2208 10.1634/stemcells.2006-0164 16778152 (Pubitemid 44527473)
41. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. Neubauer M, Fischbach C, Bauer-Kreisel P, Lieb E, Hacker M, Tessmar J, Schulz MB, Goepferich A, Blunk T, FEBS Lett 2004 577 277 283 10.1016/j.febslet.2004.10.020 15527799 (Pubitemid 39452398)